CollPlant Ltd. - Product Pipeline Analysis, 2016 Update

Report code: GDME15401PD

Publisher: GlobalData

Formats: PDF

Published: July 05, 2016

Number of pages: 36

CollPlant Ltd. (CollPlant) is a medical device company that offers tissue repair products. The company’s product categories include orthobiologics, wound care, and pipeline. Its orthobiologics products include VergenixSTR and VergenixBVF. CollPlant’s wound care products include VergenixFG, Vergenix wound dressing. Its pipeline includes bioink, VergenixTRA, and surgical wounds. CollPlant offers medical devices for tissue repair in the areas of orthopedic applications and for the advanced wound healing field. The company develops regenerative medicine by utilizing proprietary processing technologies for human collagen and other recombinant proteins. CollPlant is headquartered in Ness Ziona, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company CollPlant Ltd.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reason To Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

CollPlant Ltd. Company Snapshot 6

CollPlant Ltd. Company Overview 6

CollPlant Ltd. Pipeline Products and Clinical Trials Overview 7

CollPlant Ltd. – Pipeline Analysis Overview 9

Key Facts 9

CollPlant Ltd. - Major Products and Services 10

CollPlant Ltd. Pipeline Products by Development Stage 11

CollPlant Ltd. Clinical Trials by Trial Status 13

CollPlant Ltd. Pipeline Products Overview 14

Absorbable Bio-active Surgical Matrix - Spinal Fusion 14

Absorbable Bio-active Surgical Matrix - Spinal Fusion Product Overview 14

Vergenix STR 15

Vergenix STR Product Overview 15

Vergenix STR Clinical Trial 16

Vergenix STR - Anterior Cruciate Ligament 17

Vergenix STR - Anterior Cruciate Ligament Product Overview 17

Vergenix STR - Rotator Cuff Repair 18

Vergenix STR - Rotator Cuff Repair Product Overview 18

VergenixAR 19

VergenixAR Product Overview 19

VergenixBVF - Antibiotics 20

VergenixBVF - Antibiotics Product Overview 20

VergenixBVF - rhCollagen 21

VergenixBVF - rhCollagen Product Overview 21

VergenixDMR 22

VergenixDMR Product Overview 22

VergenixFG 23

VergenixFG Product Overview 23

VergenixFG Clinical Trial 24

VergenixGFD 25

VergenixGFD Product Overview 25

VergenixHVR 26

VergenixHVR Product Overview 26

VergenixPBR 27

VergenixPBR Product Overview 27

CollPlant Ltd. - Key Competitors 28

CollPlant Ltd. - Key Employees 29

CollPlant Ltd. - Locations And Subsidiaries 30

Head Office 30

Recent Developments 31

CollPlant Ltd., Recent Developments 31

May 31, 2016: CollPlant Receives Chief Scientist's Authorization for a NIS 12 Million Research and Development Projects with Funding of Approximately 50% 31

Feb 23, 2016: CollPlant Receives CE Mark for VergenixFG Wound Filler 31

Feb 04, 2016: CollPlant Reports Positive Final Trial Results for VergenixSTR, Indicated for the Treatment of Tendinopathy 31

Dec 08, 2015: CollPlant Reports Positive Interim Trial Results for Vergenix STR, Indicated for the Treatment of Tendinopathy 32

Nov 30, 2015: CollPlant Reports Positive Final Trial Results for VergenixFG Wound Filler 33

Oct 07, 2015: CollPlant Announces Completion of Patient Recruitment for Clinical Trial of VergenixFG (Flowable Gel) for the Treatment of Chronic Wounds 33

Sep 08, 2015: CollPlant to Present Results of its Product for the Treatment in Tendinopathy, at the 4th TERMIS Congress Which Will Take Place in Boston 34

Aug 05, 2015: CollPlant Announces Submission of CE Technical File for Vergenix FG and Successful Complementary Interim Clinical Results 34

Jul 28, 2015: CollPlant Names Shomrat Shurtz Senior Director of Business Development 35

Jul 20, 2015: CollPlant Reports Positive Interim Trial Results for Vergenix STR, for the Treatment of Tendinopathy 35

Appendix 36

Methodology 36

About GlobalData 36

Contact Us 36

Disclaimer 36

List of Tables

List of Tables

CollPlant Ltd. Pipeline Products and Clinical Trials Overview 7

CollPlant Ltd. Pipeline Products by Equipment Type 7

CollPlant Ltd. Pipeline Products by Indication 8

CollPlant Ltd. Clinical Trials by Trial Status 8

CollPlant Ltd., Key Facts 9

CollPlant Ltd., Major Products and Services 10

CollPlant Ltd. Number of Pipeline Products by Development Stage 11

CollPlant Ltd. Pipeline Products Summary by Development Stage 12

CollPlant Ltd. Clinical Trials by Trial Status 13

CollPlant Ltd. Clinical Trials Summary 13

Absorbable Bio-active Surgical Matrix - Spinal Fusion - Product Status 14

Absorbable Bio-active Surgical Matrix - Spinal Fusion - Product Description 14

Vergenix STR - Product Status 15

Vergenix STR - Product Description 15

Vergenix STR - A Prospective, Open Label, Single Arm, Multi-center Study to Assess the Safety and Performance of a Soft Tissue Repair Device (Vergenix STR) in Patients with Epicondylitis (Tennis Elbow) 16

Vergenix STR - Anterior Cruciate Ligament - Product Status 17

Vergenix STR - Anterior Cruciate Ligament - Product Description 17

Vergenix STR - Rotator Cuff Repair - Product Status 18

Vergenix STR - Rotator Cuff Repair - Product Description 18

VergenixAR - Product Status 19

VergenixAR - Product Description 19

VergenixBVF - Antibiotics - Product Status 20

VergenixBVF - Antibiotics - Product Description 20

VergenixBVF - rhCollagen - Product Status 21

VergenixBVF - rhCollagen - Product Description 21

VergenixDMR - Product Status 22

VergenixDMR - Product Description 22

VergenixFG - Product Status 23

VergenixFG - Product Description 23

VergenixFG - Single Arm, Open Label Study, to Evaluate the Safety and Performance of Vergenix Flowable Gel in Patients with Lower Limb Ulcers (CP-FG-001) 24

VergenixGFD - Product Status 25

VergenixGFD - Product Description 25

VergenixHVR - Product Status 26

VergenixHVR - Product Description 26

VergenixPBR - Product Status 27

VergenixPBR - Product Description 27

CollPlant Ltd., Key Employees 29

List of Figures

List of Figures

CollPlant Ltd. Pipeline Products by Equipment Type 8

CollPlant Ltd. Pipeline Products by Development Stage 11

CollPlant Ltd. Clinical Trials by Trial Status 13

Save time and money with a subscription

Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?

To find out more, click here or call +91 (0)40 4961 4567.

Single User License
Electronic PDF copy delivered via email.

Report can be used by individual purchaser only.

$750

Site License
Electronic PDF copy delivered via email.

Report can be shared by unlimited users within one corporate location,
e.g. a regional office.

$1500

Global License
Electronic PDF copy delivered via email.

Report can be shared globally by unlimited users within the purchasing corporation
e.g. all employees of a single company.

$2250

TOP